Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C

  • Technology appraisal guidance
  • TA75
  • Published: 
  • Last updated: 
Download guidance (PDF)

8 Related guidance

8.1 This guidance is a review of and an extension to:

  • National Institute for Clinical Excellence (2000) Guidance on the use of ribavirin and interferon alpha for hepatitis C. NICE Technology Appraisal No. 14. London: National Institute for Clinical Excellence.